Your browser doesn't support javascript.
loading
Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia.
Kim, Dae-Young; Joo, Young-Don; Lim, Sung-Nam; Kim, Sung-Doo; Lee, Jung-Hee; Lee, Je-Hwan; Kim, Dong Hwan Dennis; Kim, Kihyun; Jung, Chul Won; Kim, Inho; Yoon, Sung-Soo; Park, Seonyang; Ahn, Jae-Sook; Yang, Deok-Hwan; Lee, Je-Jung; Lee, Ho-Sup; Kim, Yang Soo; Mun, Yeung-Chul; Kim, Hawk; Park, Jae Hoo; Moon, Joon Ho; Sohn, Sang Kyun; Lee, Sang Min; Lee, Won Sik; Kim, Kyoung Ha; Won, Jong-Ho; Hyun, Myung Soo; Park, Jinny; Lee, Jae Hoon; Shin, Ho-Jin; Chung, Joo-Seop; Lee, Hyewon; Eom, Hyeon-Seok; Lee, Gyeong Won; Cho, Young-Uk; Jang, Seongsoo; Park, Chan-Jeoung; Chi, Hyun-Sook; Lee, Kyoo-Hyung.
Afiliación
  • Kim DY; Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea;
  • Joo YD; Department of Internal Medicine, Haeundae Paik Hospital, College of Medicine Inje University, Busan, Korea;
  • Lim SN; Department of Internal Medicine, Haeundae Paik Hospital, College of Medicine Inje University, Busan, Korea;
  • Kim SD; Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea;
  • Lee JH; Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea;
  • Lee JH; Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea;
  • Kim DH; Division of Hematology/Oncology, Department of Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea;
  • Kim K; Division of Hematology/Oncology, Department of Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea;
  • Jung CW; Division of Hematology/Oncology, Department of Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea;
  • Kim I; Division of Hematology-Medical Oncology, Department of Internal Medicine, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea;
  • Yoon SS; Division of Hematology-Medical Oncology, Department of Internal Medicine, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea;
  • Park S; Division of Hematology-Medical Oncology, Department of Internal Medicine, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea;
  • Ahn JS; Department of Hematology and Oncology, Chonnam National University Hwasun Hospital, Jeollanam-do, Korea;
  • Yang DH; Department of Hematology and Oncology, Chonnam National University Hwasun Hospital, Jeollanam-do, Korea;
  • Lee JJ; Department of Hematology and Oncology, Chonnam National University Hwasun Hospital, Jeollanam-do, Korea;
  • Lee HS; Division of Hematology/Oncology, Department of Internal Medicine, Kosin University College of Medicine, Kosin University Gospel Hospital, Busan, Korea;
  • Kim YS; Division of Hematology/Oncology, Department of Internal Medicine, Kosin University College of Medicine, Kosin University Gospel Hospital, Busan, Korea;
  • Mun YC; Division of Hematology-Oncology, Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, Korea;
  • Kim H; Division of Hematology and Cellular Therapy, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea;
  • Park JH; Division of Hematology and Cellular Therapy, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea;
  • Moon JH; Department of Hematology/Oncology, Kyungpook National University Hospital, Daegu, Korea;
  • Sohn SK; Department of Hematology/Oncology, Kyungpook National University Hospital, Daegu, Korea;
  • Lee SM; Department of Hemato-Oncology, Inje University Busan Paik Hospital, Busan, Korea;
  • Lee WS; Department of Hemato-Oncology, Inje University Busan Paik Hospital, Busan, Korea;
  • Kim KH; Division of Hematology-Oncology, Department of Internal Medicine, Soonchunhyang University Hospital, Soonchunhyang University College of Medicine, Seoul, Korea;
  • Won JH; Division of Hematology-Oncology, Department of Internal Medicine, Soonchunhyang University Hospital, Soonchunhyang University College of Medicine, Seoul, Korea;
  • Hyun MS; Division of Hematology-Oncology, Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Korea;
  • Park J; Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea;
  • Lee JH; Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea;
  • Shin HJ; Department of Hematology-Oncology, School of Medicine, Pusan National University Hospital Medical Research Institute, Busan, Korea;
  • Chung JS; Department of Hematology-Oncology, School of Medicine, Pusan National University Hospital Medical Research Institute, Busan, Korea;
  • Lee H; Hematologic Oncology Clinic, Center for Specific Organs Center, National Cancer Center, Goyang, Korea;
  • Eom HS; Hematologic Oncology Clinic, Center for Specific Organs Center, National Cancer Center, Goyang, Korea;
  • Lee GW; Division of Hematology-Oncology, Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Jinju, Korea; and.
  • Cho YU; Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Jang S; Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Park CJ; Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Chi HS; Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Lee KH; Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea;
Blood ; 126(6): 746-56, 2015 Aug 06.
Article en En | MEDLINE | ID: mdl-26065651
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pirimidinas / Protocolos de Quimioterapia Combinada Antineoplásica / Trasplante de Células Madre Hematopoyéticas / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pirimidinas / Protocolos de Quimioterapia Combinada Antineoplásica / Trasplante de Células Madre Hematopoyéticas / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2015 Tipo del documento: Article